AF
Andrew Fein HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
AC Immune
ACIU
$221M
| $2.20 | $12 |
445%
upside
| Buy |
1 May ‘25
4 months ago |
|
|
PVLA
27
Palvella Therapeutics, Inc. Common Stock
PVLA
$627M
| $56.71 | $38 |
33%
downside
| Buy |
30 Apr ‘25
4 months ago |
|
28
ImmunityBio
IBRX
$2.43B
| $2.57 | $8 |
211%
upside
| Buy |
28 Apr ‘25
4 months ago |
|
29
Neurocrine Biosciences
NBIX
$14.3B
| $144.17 | $168 |
17%
upside
| Buy |
22 Apr ‘25
4 months ago |
|
|
IMAB
30
I-MAB
IMAB
$376M
| $4.60 | $7 |
52%
upside
| Buy |
4 Apr ‘25
5 months ago |
|
31
Acumen Pharmaceuticals
ABOS
$87.2M
| $1.44 | $11 |
664%
upside
| Buy |
28 Mar ‘25
5 months ago |
|
32
Zentalis Pharmaceuticals
ZNTL
$115M
| $1.60 | $10 |
525%
upside
| Buy |
27 Mar ‘25
5 months ago |
|
33
Wave Life Sciences
WVE
$1.19B
| $7.48 | $22 |
194%
upside
| Buy |
26 Mar ‘25
5 months ago |
|
34
Sutro Biopharma
STRO
$82.3M
| $0.9707 | $2 |
106%
upside
| Neutral |
17 Mar ‘25
5 months ago |
|
35
ProQR Therapeutics
PRQR
$245M
| $2.33 | $12 |
415%
upside
| Buy |
14 Mar ‘25
5 months ago |
|
36
Foghorn Therapeutics
FHTX
$307M
| $5.43 | $13 |
139%
upside
| Buy |
7 Mar ‘25
6 months ago |
|
37
Protara Therapeutics
TARA
$120M
| $3.11 | $23 |
640%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
38
Kamada
KMDA
$411M
| $7.15 | $11 |
54%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
39
TScan Therapeutics
TCRX
$104M
| $1.84 | $15 |
715%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
40
Merus
MRUS
$5.18B
| $68.55 | $85 |
24%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
41
Catalyst Pharmaceutical
CPRX
$2.45B
| $20 | $35 |
75%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
42
Corbus Pharmaceuticals
CRBP
$117M
| $9.53 | $75 |
687%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
43
CG Oncology
CGON
$2.55B
| $33.47 | $75 |
124%
upside
| Buy |
13 Jan ‘25
7 months ago |
|
44
C4 Therapeutics
CCCC
$191M
| $2.68 | $7 |
161%
upside
| Buy |
2 Nov ‘23
1 year ago |
|
45
Pulmatrix
PULM
$17.4M
| $4.77 | $10 |
110%
upside
| Buy |
15 Aug ‘23
2 years ago |
|
46
MEI Pharma
MEIP
$91.3M
| $2.78 | $40 |
1,339%
upside
| Buy |
13 Feb ‘23
2 years ago |
|
47
Matinas BioPharma
MTNB
$9.11M
| $1.64 | $150 |
9,046%
upside
| Buy |
31 Jan ‘23
2 years ago |
|
|
AMRN
48
Amarin Corp
AMRN
$315M
| $15.22 | $60 |
294%
upside
| Neutral |
5 May ‘22
3 years ago |
|
49
Aldeyra Therapeutics
ALDX
$346M
| $5.76 | $15 |
160%
upside
| Buy |
27 Apr ‘22
3 years ago |
|
50
Aprea Therapeutics
APRE
$9.03M
| $1.55 | $40 |
2,481%
upside
| Neutral |
16 Mar ‘22
3 years ago |
|